Inventor

GUSTAFSON GARY

US45 patents

⚠️ This page may combine multiple inventors who share the name “GUSTAFSON GARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GUSTAFSON GARY

FORMA THERAPEUTICS INC

Compositions for activating pyruvate kinase

Activating pyruvate kinase R

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Compositions for activating pyruvate kinase

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Compositions for activating pyruvate kinase

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Activating pyruvate kinase R

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Compositions for activating pyruvate kinase

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Activating pyruvate kinase R and mutants thereof

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

NOVO NORDISK HEALTHCARE AG

Treating sickle cell disease with a pyruvate kinase R activating compound

Activating pyruvate kinase R

Activating pyruvate kinase R

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Treating sickle cell disease with a pyruvate kinase R activating compound

Activating pyruvate kinase R

FORMA TM2 INC

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

HUTCHINSON TECHNOLOGY

Reduced capacitance of electrical conductor on head suspension assembly

Method for manufacturing a head suspension having electrical trace interconnects with reduced capacitance

IBM

Apparatus and method for damping disk drive vibration

Optical fiber cable routing guide

STORAGE TECHNOLOGY CORP

Segmented power strip for an automated robotic device and method for joining same

Steering mechanism for rail guided robots in a library

POLARIS INC

Controller for steering a vehicle